The startup develops intraoperative blood auto-transfusers that recover, treat, concentrate, and re-transfuse a patient's own blood during surgery. This technology mitigates the risks of blood compatibility issues and contamination, facilitating faster recovery of red blood cells and platelets in hemorrhagic procedures.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During hemorrhagic surgeries, patients often require allogeneic blood transfusions, which carry risks of incompatibility, contamination, and post-operative complications. Traditional autotransfusion systems only recover red blood cells, limiting their effectiveness in cases of massive bleeding where platelets are also needed. Blood shortages and the high costs associated with donor blood further compound these challenges.
Solution
i-SEP offers an intraoperative cell salvage technology (IOCS) that recovers, processes, and concentrates both red blood cells and platelets from a patient's own blood during surgery. The *same™* system minimizes the need for allogeneic transfusions, reducing the risk of incompatibility and contamination while restoring the patient's immune system post-operatively. The system's filtration technology allows for the recovery of platelets, which are crucial for hemostasis and stopping bleeding. By reinfusing a patient's own blood components, i-SEP aims to improve patient outcomes, reduce healthcare costs, and alleviate pressure on blood banks.
Target Audience
The primary target audience includes cardiac surgeons, anesthesiologists, perfusionists, and hospital networks seeking to reduce reliance on allogeneic blood transfusions, improve patient blood management, and achieve cost savings.
Features
- Recovers both red blood cells (86%) and platelets (52%) during hemorrhagic surgeries
- Employs a filtration process to treat and concentrate blood components
- Offers a pre-assembled kit for quick and intuitive installation in 2-3 minutes
- Provides filtration cycles aligned with surgical time (6 min / 500 mL)
- Features intuitive software for step-by-step system guidance
- Maintains stable hematocrit concentration over treatment cycles
- Preserves platelet functionality (84%)
- Facilitates the restoration of the patient's immune system in post-operative care